Swiss pharmaceutical giant Novartis announced plans to launch a joint venture with Google to develop a high-tech contact lens that will monitor the glucose levels of diabetic patients that wear the technology.
According to reports, Novartis’s Alcon eye care unit will join secretive research lab Google X to develop the lens. The joint venture will require antitrust approval, however.
Google had already developed a prototype of the lens and first announced the product in January.
Now, Novartis will reportedly expand upon that prototype and said it is open to exploring new applications for the technology
Full content: Entrepreneur
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Canada Investigates Major Grocers for Anticompetitive Practices
May 26, 2024 by
CPI
John Hess Scrambles to Secure Shareholder Approval for $53 Billion Chevron Merger
May 26, 2024 by
CPI
Petrobras Retains Refineries and Gas Pipeline in CADE’s Landmark Reversal
May 26, 2024 by
CPI
Meta Proposes New Data Limits on Facebook Marketplace in UK Amid CMA Oversight
May 26, 2024 by
CPI
EU Industry Chief Calls for Unified Tech Regulations Between US and Europe
May 26, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI